Vitamin D Supplementation in Glomerular Disease

Completed · Not applicable

Conditions studied: Glomerular Disease

In brief

This multi-site, pilot study will assess vitamin D supplementation in children and young adults with Glomerular Disease. .

Key facts

Study ID

NCT01835639

Run by

Children's Hospital of Philadelphia

People needed

32

Starts

2013-04-01

Expected to finish

2017-09-01

Last updated by the study team

2019-08-12

Who can join

Age: 5 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females, age 5-30 years
• Diagnosis of primary glomerular disease (such as steroid-resistant nephrotic syndrome, minimal change disease, FSGS, membranous nephropathy, membranoprolfierative glomerulonephritis, and Immunoglobulin A [IgA] nephropathy) without systemic inflammatory disorders (i.e. lupus, vasculitis)
• Serum 25(OH)D level <30 ng/ml and urine protein:creatinine ratio ≥0.5 at Screening Visit.

You may not qualify if…

• Pregnancy
• estimated Glomerular Filtration Rate (eGFR) <30 ml/min/1.73m2 at Screening Visit
• Serum phosphorus > 5.5 mg/dl or hypercalcemia
• Chronic medical conditions or medications unrelated to the renal disease that may impact vitamin D status
• Known history of kidney stone(s)

Where it is running

• Nemours/Alfred I. duPont Hospital for Children — Wilmington, Delaware, United States
• Johns Hopkins University,Division of Pediatric Nephrology — Baltimore, Maryland, United States
• North Shore-Long Island Jewish Health System — New Hyde Park, New York, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• The Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.